MILLENNIUM MANAGEMENT LLC - ZYNERBA PHARMACEUTICALS INC ownership

ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is 0.41 and the average weighting 0.0%.

Quarter-by-quarter ownership
MILLENNIUM MANAGEMENT LLC ownership history of ZYNERBA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$413,051
+906.9%
325,237
+158.5%
0.00%
Q2 2023$41,022
+20829.6%
125,835
-72.4%
0.00%
Q1 2023$196
-34.0%
456,349
-18.5%
0.00%
Q4 2022$297
-99.9%
560,138
-6.3%
0.00%
Q3 2022$437,000
+26.3%
597,600
+96.9%
0.00%
Q2 2022$346,000
-78.9%
303,551
-21.7%
0.00%
-100.0%
Q3 2021$1,643,000
-20.0%
387,602
-0.2%
0.00%0.0%
Q2 2021$2,055,000
+1876.0%
388,454
+1635.7%
0.00%
Q1 2021$104,000
-84.0%
22,380
-88.6%
0.00%
-100.0%
Q3 2020$652,000
-9.9%
197,080
-8.3%
0.00%0.0%
Q2 2020$724,000
-58.2%
214,803
-6.3%
0.00%
-50.0%
Q3 2019$1,733,000
+616.1%
229,336
+1184.3%
0.00%
Q2 2019$242,000
+116.1%
17,857
-13.8%
0.00%
Q1 2019$112,000
+23.1%
20,710
-32.3%
0.00%
Q4 2018$91,000
-92.8%
30,604
-80.1%
0.00%
-100.0%
Q3 2018$1,256,000
-42.6%
153,903
-31.4%
0.00%
-33.3%
Q2 2018$2,187,000
+142.2%
224,511
+116.0%
0.00%
+200.0%
Q1 2018$903,000
+216.8%
103,941
+519.7%
0.00%0.0%
Q2 2017$285,000
-54.7%
16,772
-46.4%
0.00%0.0%
Q1 2017$629,00031,2980.00%
Other shareholders
ZYNERBA PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
RA Capital Management 507,191$5,107,0000.50%
Cormorant Asset Management, LP 356,600$3,591,0000.43%
Perceptive Advisors 558,446$5,623,0000.42%
NEXTHERA CAPITAL LP 15,000$151,0000.21%
EMERALD ADVISERS, LLC 237,070$2,387,0000.11%
AUXIER ASSET MANAGEMENT 17,857$180,0000.04%
FEDERATED HERMES, INC. 450,000$4,532,0000.01%
Nationwide Fund Advisors 49,473$498,0000.00%
Catalyst Capital Advisors LLC 348$4,0000.00%
DEUTSCHE BANK AG\ 859$8,0000.00%
View complete list of ZYNERBA PHARMACEUTICALS INC shareholders